Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.

× No keyword cloud information.

12 in total

1. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors: Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal: Int Arch Allergy Immunol Date: 2011-10-27 Impact factor: 2.749

2. Detection of circulating mast cells in advanced systemic mastocytosis.

Authors: J S Dahlin; J S Ungerstedt; J Grootens; B Sander; T Gülen; H Hägglund; G Nilsson
Journal: Leukemia Date: 2016-04-27 Impact factor: 11.528

Review 3. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Authors: P Valent; K Sotlar; W R Sperr; L Escribano; S Yavuz; A Reiter; T I George; H C Kluin-Nelemans; O Hermine; J H Butterfield; H Hägglund; C Ustun; J L Hornick; M Triggiani; D Radia; C Akin; K Hartmann; J Gotlib; L B Schwartz; S Verstovsek; A Orfao; D D Metcalfe; M Arock; H-P Horny
Journal: Ann Oncol Date: 2014-03-27 Impact factor: 32.976

Review 4. Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.

Authors: Oscar González-López; Javier I Muñoz-González; Alberto Orfao; Iván Álvarez-Twose; Andrés C García-Montero
Journal: Cancers (Basel) Date: 2022-05-18 Impact factor: 6.575

5. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.

Authors: Jason Gotlib; Animesh Pardanani; Cem Akin; Andreas Reiter; Tracy George; Olivier Hermine; Hanneke Kluin-Nelemans; Karin Hartmann; Wolfgang R Sperr; Knut Brockow; Lawrence B Schwartz; Alberto Orfao; Daniel J Deangelo; Michel Arock; Karl Sotlar; Hans-Peter Horny; Dean D Metcalfe; Luis Escribano; Srdan Verstovsek; Ayalew Tefferi; Peter Valent
Journal: Blood Date: 2013-01-16 Impact factor: 22.113

6. Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.

Authors: Peter Valent
Journal: Am J Cancer Res Date: 2013-04-03 Impact factor: 6.166

7. Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive.

Authors: Magalie Joris; Sophie Georgin-Lavialle; Marie-Olivia Chandesris; Ludovic Lhermitte; Jean-François Claisse; Danielle Canioni; Katia Hanssens; Gandhi Damaj; Olivier Hermine; Mohammed Hamidou
Journal: Case Rep Hematol Date: 2012-09-10

Review 8. Standards and impact of hematopathology in myelodysplastic syndromes (MDS).

Authors: Peter Valent; Attilio Orazi; Guntram Büsche; Annette Schmitt-Gräff; Tracy I George; Karl Sotlar; Berthold Streubel; Christine Beham-Schmid; Sabine Cerny-Reiterer; Otto Krieger; Arjan van de Loosdrecht; Wolfgang Kern; Kiyoyuki Ogata; Friedrich Wimazal; Judit Várkonyi; Wolfgang R Sperr; Martin Werner; Hans Kreipe; Hans-Peter Horny
Journal: Oncotarget Date: 2010-11

9. The First Case of Therapy-Related Myelomastocytic Leukemia Based on the WHO 2008 Classification and the Recently Proposed Diagnostic Criteria.

Authors: Won Kyu Choi; Young Uk Cho; Eunkyoung You; Seongsoo Jang; Eul Ju Seo; Chan Jeoung Park
Journal: Ann Lab Med Date: 2017-05 Impact factor: 3.464

10. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.

Authors: Yalin Zheng; Lin Nong; Li Liang; Wei Wang; Ting Li
Journal: Diagn Pathol Date: 2018-02-20 Impact factor: 2.644